Veradigm Total Current Liabilities 2010-2022 | MDRX
Veradigm total current liabilities from 2010 to 2022. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Veradigm Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2022 | $230 |
| 2021 | $488 |
| 2020 | $935 |
| 2019 | $1,211 |
| 2018 | $798 |
| 2017 | $890 |
| 2016 | $667 |
| 2015 | $513 |
| 2014 | $521 |
| 2013 | $517 |
| 2012 | $518 |
| 2011 | $497 |
| 2010 | $431 |
| 2010 | $212 |
| 2009 | $164 |
| Veradigm Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2022-12-31 | $230 |
| 2022-09-30 | $253 |
| 2022-06-30 | $256 |
| 2022-03-31 | $647 |
| 2021-12-31 | $488 |
| 2021-09-30 | $567 |
| 2021-06-30 | $596 |
| 2021-03-31 | $880 |
| 2020-12-31 | $935 |
| 2020-09-30 | $745 |
| 2020-06-30 | $1,111 |
| 2020-03-31 | $1,158 |
| 2019-12-31 | $1,211 |
| 2019-09-30 | $1,177 |
| 2019-06-30 | $880 |
| 2019-03-31 | $800 |
| 2018-12-31 | $798 |
| 2018-09-30 | $894 |
| 2018-06-30 | $907 |
| 2018-03-31 | $889 |
| 2017-12-31 | $890 |
| 2017-09-30 | $684 |
| 2017-06-30 | $672 |
| 2017-03-31 | $698 |
| 2016-12-31 | $667 |
| 2016-09-30 | $626 |
| 2016-06-30 | $607 |
| 2016-03-31 | $543 |
| 2015-12-31 | $513 |
| 2015-09-30 | $490 |
| 2015-06-30 | $521 |
| 2015-03-31 | $538 |
| 2014-12-31 | $521 |
| 2014-09-30 | $524 |
| 2014-06-30 | $518 |
| 2014-03-31 | $529 |
| 2013-12-31 | $517 |
| 2013-09-30 | $520 |
| 2013-06-30 | $539 |
| 2013-03-31 | $627 |
| 2012-12-31 | $518 |
| 2012-09-30 | $540 |
| 2012-06-30 | $563 |
| 2012-03-31 | $555 |
| 2011-12-31 | $497 |
| 2011-09-30 | $463 |
| 2011-06-30 | $488 |
| 2011-03-31 | $452 |
| 2010-12-31 | $431 |
| 2010-09-30 | $385 |
| 2010-06-30 | |
| 2010-05-31 | $212 |
| 2010-03-31 | |
| 2010-02-28 | $191 |
| 2009-12-31 | $157 |
| 2009-11-30 | $158 |
| 2009-09-30 | |
| 2009-08-31 | $158 |
| 2009-05-31 | $164 |
| 2009-02-28 | $171 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.531B | $0.588B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.130B | 58.69 |
| Doximity (DOCS) | United States | $11.290B | 52.27 |
| Hims & Hers Health (HIMS) | United States | $11.277B | 117.16 |
| Tempus AI (TEM) | United States | $10.557B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.350B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.741B | 58.45 |
| Hinge Health (HNGE) | United States | $3.664B | 0.00 |
| Privia Health (PRVA) | United States | $2.391B | 163.42 |
| Schrodinger (SDGR) | United States | $1.574B | 0.00 |
| Phreesia (PHR) | United States | $1.516B | 0.00 |
| Enovis (ENOV) | United States | $1.502B | 8.37 |
| Clover Health Investments (CLOV) | United States | $1.496B | 0.00 |
| 10x Genomics (TXG) | United States | $1.496B | 0.00 |
| Azenta (AZTA) | United States | $1.427B | 66.30 |
| Omnicell (OMCL) | United States | $1.259B | 22.22 |
| Evolent Health (EVH) | United States | $1.119B | 95.30 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.541B | 0.00 |
| Standard BioTools (LAB) | United States | $0.467B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.462B | 0.00 |
| Talkspace (TALK) | United States | $0.415B | 124.00 |
| TruBridge (TBRG) | United States | $0.336B | 746.33 |
| Outset Medical (OM) | United States | $0.309B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.280B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| CapsoVision (CV) | United States | $0.211B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.155B | 0.00 |
| Pulmonx (LUNG) | United States | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.85 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.079B | 0.00 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |